top of page
MVT: In the News
Search
Sep 16, 2024
Microvascular Therapeutics and Cordance Medical Announce Strategic Partnership
Tucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...
Sep 12, 2024
MVT and Soundjet Announce Collaboration Aiming to Bring New Treatment Options to Patients with Vascular Thrombosis
Microvascular Therapeutics, Inc. (MVT), and SoundJet Medical, Inc. (SoundJet) announce that they have entered into a strategic...
Sep 5, 2024
Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100
Tucson, AZ – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased to announce the...
Sep 4, 2024
MVT’s Founder, Dr. Evan Unger, Receives 2024 Harry Fischer Award for Excellence in Contrast Media Research
Tucson, AZ Â - Dr. Evan Unger, CEO and Founder of Microvascular Therapeutics (MVT), has been awarded the 2024 Harry Fischer Award by...
Feb 9, 2024
Microvascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum
Microvascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum [Tucson, AZ] – Microvascular Therapeutics Inc....
Feb 8, 2024
Microvascular Therapeutics welcomes Thom Tulip as Chief Business Officer
[Tucson, Arizona] – [2/05/2024] – Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing...
Dec 12, 2023
Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator Program
Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has...
Dec 12, 2023
Breakthrough Study by Microvascular Therapeutics Reveals Fibrin-Targeted Phase Shift Microbubbles as
Microvascular Therapeutics, a trailblazing healthcare research and development company, announces a groundbreaking study on the treatment...
Nov 30, 2022
Nov 21, 2022
Feb 28, 2022
Timothy Healey Joins the Board of Directors at Microvascular Therapeutics
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Timothy...
Feb 8, 2022
ImaRx Investments Receives ISO-7 Certification for Its GMP Manufacturing Suite
ImaRx Investments, LLC, an investment firm based in Tucson, Arizona, has received ISO-7 certification on February 1st for its GMP...
bottom of page